Lionco Pharmaceutical Group Co., Ltd.SSE: 603669

Announcement on Engagement of Audit Institution for 2025

· Issued by Lionco Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 5 pages · Chinese

Summary by 6ix AI

This change is aimed at ensuring the smooth progress of the annual audit work, considering the company's business needs. The decision has been communicated with the previous auditor, who has no objections to the change.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Lionco Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Lionco Pharmaceutical

Later from Lionco Pharmaceutical

All Lionco Pharmaceutical news releases